Search

Search Constraints

You searched for: Author/Creator Zocholl, Dario

Search Results

1. 2022-RA-1192-ESGO NOGGO ov44 – PERCEPTION What is the role of immunotherapy in low grade ovarian cancer? A NOGGO phase II trial of pembrolizumab in combination with chemotherapy in recurrent low-grade serous ovarian cancer. (20th October 2022)

2. 2022-RA-1564-ESGO Patients' perspectives on changes in cancer care during the COVID-19 pandemic: Results of a German survey among patients with gynecological malignancies. (20th October 2022)

3. 2022-RA-296-ESGO Non-pharmacological, patient-related predictive model for the occurrence of CINV: prospective, multicentre study in Germany (NOGGO-EMRISK trial). (20th October 2022)

4. 2022-RA-367-ESGO Rucaparib in clinical practice – what are the elements of patient adherence?. (20th October 2022)

5. 2022-RA-837-ESGO Characterization of long-term survivor and maintenance therapy in relapsed ovarian cancer (CAROLIN)- Intergroup study NOGGO/A-AGO. (20th October 2022)

7. Prevalence estimates of major depressive disorder in 27 European countries from the European Health Interview Survey: accounting for imperfect diagnostic accuracy of the PHQ-8. Issue 1 (6th April 2023)

8. Proinflammatory and bone protective role of calcitonin gene-related peptide alpha in collagen antibody-induced arthritis. (22nd November 2020)

10. TP038/#1408 Rucaparib maintenance after bevacizumab maintenance following carboplatin based first line chemotherapy in ovarian cancer. (4th December 2022)